Autoimmune Disease Diagnostics Market Size, Share, Growth, Trends, and Global Industry Analysis: By Type (Systemic Autoimmune Disease, Local Autoimmune Disease), By Disease (Diabetes Type-1, Rheumatoid Arthritis, Multiple Sclerosis, Others), By End user (Diagnostic Centers, Hospitals, Research Laboratories, Others) and Region

Autoimmune Disease Diagnostics Market size was valued at US$ 4.2 billion in 2022 and is anticipated to grow at US$ 6.4 billion till 2029 recording a CAGR of 8.9% during the forecast period 2023-2029. The immune system protects the body from infections and diseases. In autoimmune disorders, low or overactivity of the immune system may appear. There is no exact cause of autoimmune diseases is identified. In response to an unknown trigger, the immune system produces antibodies that instead of fighting infections, attack the body's own tissues. Autoimmune diseases are diagnosed with blood tests and a review of disease history, symptoms, and physical examination. Rheumatoid arthritis, type-1 diabetes, multiple sclerosis, and lupus are some of the major autoimmune diseases. The global autoimmune disease diagnostics market is expected to grow at a significant rate owing to growing rates of autoimmune diseases. According to the National Multiple Sclerosis Society (MS), approximately, 2.3 Mn people are living with multiple sclerosis worldwide. The market is composed of multinational and local companies involved in offering autoimmune diagnostics. Major players are involved in R&D for the development and introduction of new diagnostics into the market. Market players are collaborating in order to develop new diagnostics for autoimmune diseases and further increase the market portfolio. For instance, in November 2014, Protagen AG entered into a long-term collaboration with Qiagen to develop an innovative companion diagnostic development platform for autoimmune disorders. Furthermore, government and non-profit organizations are taking initiatives to increase awareness and involving in development of diagnostics for autoimmune diseases.